Arteris (NASDAQ:AIP - Get Free Report) is scheduled to be posting its quarterly earnings results after the market closes on Tuesday, November 5th. Analysts expect Arteris to post earnings of ($0.14) per share for the quarter. Arteris has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Parties that are interested in participating in the company's conference call can do so using this link.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.14) by ($0.07). Arteris had a negative return on equity of 274.66% and a negative net margin of 68.37%. The company had revenue of $14.58 million during the quarter, compared to analysts' expectations of $13.68 million. During the same period in the previous year, the firm posted ($0.25) EPS. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Arteris Price Performance
Shares of NASDAQ AIP traded up $0.12 during trading on Tuesday, hitting $7.23. The company had a trading volume of 62,087 shares, compared to its average volume of 163,545. Arteris has a fifty-two week low of $4.20 and a fifty-two week high of $9.54. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 0.17. The stock has a fifty day simple moving average of $7.46 and a two-hundred day simple moving average of $7.63. The firm has a market capitalization of $278.20 million, a price-to-earnings ratio of -6.83 and a beta of 1.11.
Insiders Place Their Bets
In other Arteris news, CFO Nicholas B. Hawkins sold 11,628 shares of the company's stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $7.86, for a total value of $91,396.08. Following the completion of the sale, the chief financial officer now directly owns 224,659 shares in the company, valued at $1,765,819.74. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CFO Nicholas B. Hawkins sold 11,628 shares of the firm's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $7.86, for a total transaction of $91,396.08. Following the completion of the sale, the chief financial officer now owns 224,659 shares in the company, valued at $1,765,819.74. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Paul L. Alpern sold 11,250 shares of the company's stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $7.71, for a total value of $86,737.50. Following the completion of the transaction, the vice president now owns 74,563 shares in the company, valued at $574,880.73. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 135,360 shares of company stock valued at $988,781 in the last ninety days. 33.70% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
A number of equities analysts have commented on the company. Westpark Capital reissued a "buy" rating and set a $11.00 target price on shares of Arteris in a report on Wednesday, July 31st. Rosenblatt Securities reissued a "buy" rating and issued a $15.00 price objective on shares of Arteris in a research note on Monday, August 5th.
Get Our Latest Stock Report on Arteris
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Stories
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.